Andrea Derix

Andrea Derix currently serves as the VP and Senior Global Program Team Leader at Die Grünenthal Gruppe, overseeing a global late-stage development program for Osteoarthritis pain management while managing strategy and budget responsibilities. Prior experience includes various leadership roles at Bayer Pharmaceuticals, such as VP and Senior Global Program Head for Thrombosis and Xarelto, where Andrea guided cross-functional teams in clinical development and external collaborations, including initiatives in Digital Health. Career beginnings include regulatory affairs management at PAION Deutschland GmbH and Takeda Pharmaceuticals. Andrea holds a Master of Drug Regulatory Affairs from The University of Bonn, a Ph.D. in Natural Sciences/Pharmacy from the University of Düsseldorf, and a Staatsexamen in Pharmacy from The University of Bonn.